MALDI-TOF Protein Profiling Reflects Changes in Type 1 Diabetes Patients Depending on the Increased Amount of Adipose Tissue, Poor Control of Diabetes and the Presence of Chronic Complications
Authors:
Open Access
- 25 February 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (5) , 2263
Abstract
Introduction: Protein profiling allows the determination of the presence of proteins marking various stages of the disease, and differentiates between people at risk of various diseases. In type 1 diabetes, protein profiling had been previously used to find blood markers other than islet autoantibodies to indicate the pancreatic beta cell destruction process and to reflect the progression of type 1 diabetes mellitus (T1DM). However, T1DM is an auto-immune disease and its clinical presentation changes in time of its duration. The aim of the study: To find differences in protein profiles in patients with type 1 diabetes according to diabetes control (HbA1c > 7%) and with presence of diabetic complications or obesity. It may help to identify subgroups of patients who may need a better clinical supervision and individualized treatment. Material and methods: A group of 103 patients with auto-immunologically confirmed T1DM, and meeting the following inclusion criteria: Caucasian race, duration of diabetes >5 years, were used in the study. Criteria of exclusion: past or present cancer (treated with chemo-/radiotherapy), diseases of the liver (ALT > 3 × ULN) except for people with simple hepatic steatosis, chronic renal disease (eGFR < 30 mL/1.73 m2/min), and acute inflammation (CRP > 5 mg/dL). The study group was divided in terms of the presence of chronic complications, obesity, or poor metabolic control (HbA1c > 7%). Protein profiling was completed by using the MALDI-TOF MS (matrix-assisted laser desorption/ionization-time of flight mass spectrometry) analyzer. Results: Differentiating proteins were identified in all of the groups. The groups burdened with complications, obesity, and poor metabolic control were characterized by increased levels of fibrinogen, complement C4 and C3. Conclusion: The groups of type 1 diabetes patients burdened with complications, obesity, and poor metabolic control were characterized by increased levels of fibrinogen, complement C4 and C3. Further detailed studies are necessary to determine more subtle changes in the proteomic profile of patients with type 1 diabetes.Keywords
Funding Information
- Young Scientists Grant of the Poznan University of Medical Sciences. (502-14-0222-3800-10838)
This publication has 19 references indexed in Scilit:
- Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 DiabetesPLOS ONE, 2015
- Global epidemiology of type 1 diabetes in young adults and adults: a systematic reviewBMC Public Health, 2015
- Increased Complement Activation in Human Type 1 Diabetes PancreataDiabetes Care, 2013
- Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetesJournal of Experimental Medicine, 2012
- Discovery and Validation of Serum Protein Changes in Type 1 Diabetes Patients Using High Throughput Two Dimensional Liquid Chromatography-Mass Spectrometry and ImmunoassaysMolecular & Cellular Proteomics, 2011
- Good glycemic control remains crucial in prevention of late diabetic complications - the Linköping Diabetes Complications StudyPediatric Diabetes, 2009
- Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complicationsDiabetes Research and Clinical Practice, 2008
- Proteomics and Diabetic NephropathySeminars in Nephrology, 2007
- Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathyDiabetologia, 2007
- Association between PON 1 polymorphisms, PON activity and diabetes complicationsJournal of Diabetes and its Complications, 2006